BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.
Identifieur interne : 002B96 ( Main/Exploration ); précédent : 002B95; suivant : 002B97BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.
Auteurs : Suneil K. Kalia [Canada] ; Sang Lee ; Patrice D. Smith ; Li Liu ; Stephen J. Crocker ; Thorhildur E. Thorarinsdottir ; John R. Glover ; Edward A. Fon ; David S. Park ; Andres M. LozanoSource :
- Neuron [ 0896-6273 ] ; 2004.
English descriptors
- KwdEn :
- Adaptor Proteins, Signal Transducing (genetics), Adaptor Proteins, Signal Transducing (physiology), Amino Acid Sequence, Animals, Carrier Proteins (genetics), Carrier Proteins (physiology), Cell Line, Tumor, Dopamine (genetics), Dopamine (metabolism), HSP70 Heat-Shock Proteins (antagonists & inhibitors), HSP70 Heat-Shock Proteins (genetics), HSP70 Heat-Shock Proteins (metabolism), Humans, Mice, Molecular Sequence Data, NIH 3T3 Cells, Nerve Degeneration (genetics), Nerve Degeneration (metabolism), Nerve Degeneration (pathology), Parkinson Disease (metabolism), Parkinson Disease (pathology), Proto-Oncogene Proteins c-bcl-2 (genetics), Proto-Oncogene Proteins c-bcl-2 (metabolism), Rats, Ubiquitin-Protein Ligases (antagonists & inhibitors), Ubiquitin-Protein Ligases (genetics), Ubiquitin-Protein Ligases (metabolism).
- MESH :
- chemical , antagonists & inhibitors : HSP70 Heat-Shock Proteins, Ubiquitin-Protein Ligases.
- chemical , genetics : Adaptor Proteins, Signal Transducing, Carrier Proteins, Dopamine, HSP70 Heat-Shock Proteins, Proto-Oncogene Proteins c-bcl-2, Ubiquitin-Protein Ligases.
- chemical , metabolism : Dopamine, HSP70 Heat-Shock Proteins, Proto-Oncogene Proteins c-bcl-2, Ubiquitin-Protein Ligases.
- chemical , physiology : Adaptor Proteins, Signal Transducing, Carrier Proteins.
- genetics : Nerve Degeneration.
- metabolism : Nerve Degeneration, Parkinson Disease.
- pathology : Nerve Degeneration, Parkinson Disease.
- Amino Acid Sequence, Animals, Cell Line, Tumor, Humans, Mice, Molecular Sequence Data, NIH 3T3 Cells, Rats.
Abstract
Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, are the major cause of early-onset Parkinson's disease (PD). Decreases in parkin activity may also contribute to neurodegeneration in sporadic forms of PD. Here, we show that bcl-2-associated athanogene 5 (BAG5), a BAG family member, directly interacts with parkin and the chaperone Hsp70. Within this complex, BAG5 inhibits both parkin E3 ubiquitin ligase activity and Hsp70-mediated refolding of misfolded proteins. BAG5 enhances parkin sequestration within protein aggregates and mitigates parkin-dependent preservation of proteasome function. Finally, BAG5 enhances dopamine neuron death in an in vivo model of PD, whereas a mutant that inhibits BAG5 activity attenuates dopaminergic neurodegeneration. This contrasts with the antideath functions ascribed to BAG family members and suggests a potential role for BAG5 in promoting neurodegeneration in sporadic PD through its functional interactions with parkin and Hsp70.
DOI: 10.1016/j.neuron.2004.11.026
PubMed: 15603737
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001308
- to stream PubMed, to step Curation: 001308
- to stream PubMed, to step Checkpoint: 001308
- to stream Ncbi, to step Merge: 000481
- to stream Ncbi, to step Curation: 000481
- to stream Ncbi, to step Checkpoint: 000481
- to stream Main, to step Merge: 002F54
- to stream Main, to step Curation: 002B96
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.</title>
<author><name sortKey="Kalia, Suneil K" sort="Kalia, Suneil K" uniqKey="Kalia S" first="Suneil K" last="Kalia">Suneil K. Kalia</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied and Interventional Research, Toronto Western Hospital Research Institute, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Applied and Interventional Research, Toronto Western Hospital Research Institute, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario M5T 2S8</wicri:regionArea>
<wicri:noRegion>Ontario M5T 2S8</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lee, Sang" sort="Lee, Sang" uniqKey="Lee S" first="Sang" last="Lee">Sang Lee</name>
</author>
<author><name sortKey="Smith, Patrice D" sort="Smith, Patrice D" uniqKey="Smith P" first="Patrice D" last="Smith">Patrice D. Smith</name>
</author>
<author><name sortKey="Liu, Li" sort="Liu, Li" uniqKey="Liu L" first="Li" last="Liu">Li Liu</name>
</author>
<author><name sortKey="Crocker, Stephen J" sort="Crocker, Stephen J" uniqKey="Crocker S" first="Stephen J" last="Crocker">Stephen J. Crocker</name>
</author>
<author><name sortKey="Thorarinsdottir, Thorhildur E" sort="Thorarinsdottir, Thorhildur E" uniqKey="Thorarinsdottir T" first="Thorhildur E" last="Thorarinsdottir">Thorhildur E. Thorarinsdottir</name>
</author>
<author><name sortKey="Glover, John R" sort="Glover, John R" uniqKey="Glover J" first="John R" last="Glover">John R. Glover</name>
</author>
<author><name sortKey="Fon, Edward A" sort="Fon, Edward A" uniqKey="Fon E" first="Edward A" last="Fon">Edward A. Fon</name>
</author>
<author><name sortKey="Park, David S" sort="Park, David S" uniqKey="Park D" first="David S" last="Park">David S. Park</name>
</author>
<author><name sortKey="Lozano, Andres M" sort="Lozano, Andres M" uniqKey="Lozano A" first="Andres M" last="Lozano">Andres M. Lozano</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15603737</idno>
<idno type="pmid">15603737</idno>
<idno type="doi">10.1016/j.neuron.2004.11.026</idno>
<idno type="wicri:Area/PubMed/Corpus">001308</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001308</idno>
<idno type="wicri:Area/PubMed/Curation">001308</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001308</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001308</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001308</idno>
<idno type="wicri:Area/Ncbi/Merge">000481</idno>
<idno type="wicri:Area/Ncbi/Curation">000481</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000481</idno>
<idno type="wicri:doubleKey">0896-6273:2004:Kalia S:bag:inhibits:parkin</idno>
<idno type="wicri:Area/Main/Merge">002F54</idno>
<idno type="wicri:Area/Main/Curation">002B96</idno>
<idno type="wicri:Area/Main/Exploration">002B96</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">BAG5 inhibits parkin and enhances dopaminergic neuron degeneration.</title>
<author><name sortKey="Kalia, Suneil K" sort="Kalia, Suneil K" uniqKey="Kalia S" first="Suneil K" last="Kalia">Suneil K. Kalia</name>
<affiliation wicri:level="1"><nlm:affiliation>Applied and Interventional Research, Toronto Western Hospital Research Institute, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario M5T 2S8, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Applied and Interventional Research, Toronto Western Hospital Research Institute, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario M5T 2S8</wicri:regionArea>
<wicri:noRegion>Ontario M5T 2S8</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lee, Sang" sort="Lee, Sang" uniqKey="Lee S" first="Sang" last="Lee">Sang Lee</name>
</author>
<author><name sortKey="Smith, Patrice D" sort="Smith, Patrice D" uniqKey="Smith P" first="Patrice D" last="Smith">Patrice D. Smith</name>
</author>
<author><name sortKey="Liu, Li" sort="Liu, Li" uniqKey="Liu L" first="Li" last="Liu">Li Liu</name>
</author>
<author><name sortKey="Crocker, Stephen J" sort="Crocker, Stephen J" uniqKey="Crocker S" first="Stephen J" last="Crocker">Stephen J. Crocker</name>
</author>
<author><name sortKey="Thorarinsdottir, Thorhildur E" sort="Thorarinsdottir, Thorhildur E" uniqKey="Thorarinsdottir T" first="Thorhildur E" last="Thorarinsdottir">Thorhildur E. Thorarinsdottir</name>
</author>
<author><name sortKey="Glover, John R" sort="Glover, John R" uniqKey="Glover J" first="John R" last="Glover">John R. Glover</name>
</author>
<author><name sortKey="Fon, Edward A" sort="Fon, Edward A" uniqKey="Fon E" first="Edward A" last="Fon">Edward A. Fon</name>
</author>
<author><name sortKey="Park, David S" sort="Park, David S" uniqKey="Park D" first="David S" last="Park">David S. Park</name>
</author>
<author><name sortKey="Lozano, Andres M" sort="Lozano, Andres M" uniqKey="Lozano A" first="Andres M" last="Lozano">Andres M. Lozano</name>
</author>
</analytic>
<series><title level="j">Neuron</title>
<idno type="ISSN">0896-6273</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adaptor Proteins, Signal Transducing (genetics)</term>
<term>Adaptor Proteins, Signal Transducing (physiology)</term>
<term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Carrier Proteins (genetics)</term>
<term>Carrier Proteins (physiology)</term>
<term>Cell Line, Tumor</term>
<term>Dopamine (genetics)</term>
<term>Dopamine (metabolism)</term>
<term>HSP70 Heat-Shock Proteins (antagonists & inhibitors)</term>
<term>HSP70 Heat-Shock Proteins (genetics)</term>
<term>HSP70 Heat-Shock Proteins (metabolism)</term>
<term>Humans</term>
<term>Mice</term>
<term>Molecular Sequence Data</term>
<term>NIH 3T3 Cells</term>
<term>Nerve Degeneration (genetics)</term>
<term>Nerve Degeneration (metabolism)</term>
<term>Nerve Degeneration (pathology)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson Disease (pathology)</term>
<term>Proto-Oncogene Proteins c-bcl-2 (genetics)</term>
<term>Proto-Oncogene Proteins c-bcl-2 (metabolism)</term>
<term>Rats</term>
<term>Ubiquitin-Protein Ligases (antagonists & inhibitors)</term>
<term>Ubiquitin-Protein Ligases (genetics)</term>
<term>Ubiquitin-Protein Ligases (metabolism)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>HSP70 Heat-Shock Proteins</term>
<term>Ubiquitin-Protein Ligases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Adaptor Proteins, Signal Transducing</term>
<term>Carrier Proteins</term>
<term>Dopamine</term>
<term>HSP70 Heat-Shock Proteins</term>
<term>Proto-Oncogene Proteins c-bcl-2</term>
<term>Ubiquitin-Protein Ligases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Dopamine</term>
<term>HSP70 Heat-Shock Proteins</term>
<term>Proto-Oncogene Proteins c-bcl-2</term>
<term>Ubiquitin-Protein Ligases</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Adaptor Proteins, Signal Transducing</term>
<term>Carrier Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Nerve Degeneration</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Nerve Degeneration</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Nerve Degeneration</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Cell Line, Tumor</term>
<term>Humans</term>
<term>Mice</term>
<term>Molecular Sequence Data</term>
<term>NIH 3T3 Cells</term>
<term>Rats</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Loss-of-function mutations in the parkin gene, which encodes an E3 ubiquitin ligase, are the major cause of early-onset Parkinson's disease (PD). Decreases in parkin activity may also contribute to neurodegeneration in sporadic forms of PD. Here, we show that bcl-2-associated athanogene 5 (BAG5), a BAG family member, directly interacts with parkin and the chaperone Hsp70. Within this complex, BAG5 inhibits both parkin E3 ubiquitin ligase activity and Hsp70-mediated refolding of misfolded proteins. BAG5 enhances parkin sequestration within protein aggregates and mitigates parkin-dependent preservation of proteasome function. Finally, BAG5 enhances dopamine neuron death in an in vivo model of PD, whereas a mutant that inhibits BAG5 activity attenuates dopaminergic neurodegeneration. This contrasts with the antideath functions ascribed to BAG family members and suggests a potential role for BAG5 in promoting neurodegeneration in sporadic PD through its functional interactions with parkin and Hsp70.</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
</country>
</list>
<tree><noCountry><name sortKey="Crocker, Stephen J" sort="Crocker, Stephen J" uniqKey="Crocker S" first="Stephen J" last="Crocker">Stephen J. Crocker</name>
<name sortKey="Fon, Edward A" sort="Fon, Edward A" uniqKey="Fon E" first="Edward A" last="Fon">Edward A. Fon</name>
<name sortKey="Glover, John R" sort="Glover, John R" uniqKey="Glover J" first="John R" last="Glover">John R. Glover</name>
<name sortKey="Lee, Sang" sort="Lee, Sang" uniqKey="Lee S" first="Sang" last="Lee">Sang Lee</name>
<name sortKey="Liu, Li" sort="Liu, Li" uniqKey="Liu L" first="Li" last="Liu">Li Liu</name>
<name sortKey="Lozano, Andres M" sort="Lozano, Andres M" uniqKey="Lozano A" first="Andres M" last="Lozano">Andres M. Lozano</name>
<name sortKey="Park, David S" sort="Park, David S" uniqKey="Park D" first="David S" last="Park">David S. Park</name>
<name sortKey="Smith, Patrice D" sort="Smith, Patrice D" uniqKey="Smith P" first="Patrice D" last="Smith">Patrice D. Smith</name>
<name sortKey="Thorarinsdottir, Thorhildur E" sort="Thorarinsdottir, Thorhildur E" uniqKey="Thorarinsdottir T" first="Thorhildur E" last="Thorarinsdottir">Thorhildur E. Thorarinsdottir</name>
</noCountry>
<country name="Canada"><noRegion><name sortKey="Kalia, Suneil K" sort="Kalia, Suneil K" uniqKey="Kalia S" first="Suneil K" last="Kalia">Suneil K. Kalia</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002B96 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002B96 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Canada |area= ParkinsonCanadaV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:15603737 |texte= BAG5 inhibits parkin and enhances dopaminergic neuron degeneration. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:15603737" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a ParkinsonCanadaV1
This area was generated with Dilib version V0.6.29. |